Abstract
The porphyrins and related tetrapyrrole systems are among the most widely studied of all macrocyclic compounds. In fact, in one capacity or another these versatile molecules have influenced nearly all disciplines in chemistry. In recent years, efforts are underway to develop tetrahydroporphyrin-based (bacteriochlorin) compounds with long wavelength absorption in the range of 700-800 nm as photosensitizers for photodynamic therapy (PDT). This review article summarizes the synthetic methodologies that have been developed for the preparation of a variety of bacteriochlorins, either from porphyrins or chlorin systems.
Keywords: bacteriochlorins photodynamictherapy (pdt), tetrapyrrole systems, photosensitizers
Current Organic Chemistry
Title: Synthesis of Bacteriochlorins and Their Potential Utility in Photodynamic Therapy (PDT)
Volume: 8 Issue: 12
Author(s): Yihui Chen, Guolin Li and Ravindra K. Pandey
Affiliation:
Keywords: bacteriochlorins photodynamictherapy (pdt), tetrapyrrole systems, photosensitizers
Abstract: The porphyrins and related tetrapyrrole systems are among the most widely studied of all macrocyclic compounds. In fact, in one capacity or another these versatile molecules have influenced nearly all disciplines in chemistry. In recent years, efforts are underway to develop tetrahydroporphyrin-based (bacteriochlorin) compounds with long wavelength absorption in the range of 700-800 nm as photosensitizers for photodynamic therapy (PDT). This review article summarizes the synthetic methodologies that have been developed for the preparation of a variety of bacteriochlorins, either from porphyrins or chlorin systems.
Export Options
About this article
Cite this article as:
Chen Yihui, Li Guolin and Pandey K. Ravindra, Synthesis of Bacteriochlorins and Their Potential Utility in Photodynamic Therapy (PDT), Current Organic Chemistry 2004; 8 (12) . https://dx.doi.org/10.2174/1385272043370131
DOI https://dx.doi.org/10.2174/1385272043370131 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Somatostatin Receptor-Targeted Anti-Cancer Therapy
Current Drug Delivery Can Mycobacterial Genomics Generate Novel Targets as Speed-Breakers Against the Race for Drug Resistance
Current Pharmaceutical Design Plant Troponoids: Chemistry, Biological Activity, and Biosynthesis
Current Medicinal Chemistry The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells
Current Medicinal Chemistry - Anti-Cancer Agents Recombinant Adeno-associated Virus 9-mediated Expression of Kallistatin Suppresses Lung Tumor Growth in Mice
Current Gene Therapy Interferon: Cellular Executioner or White Knight?
Current Medicinal Chemistry Matrine: Bioactivities and Structural Modifications
Current Topics in Medicinal Chemistry The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Current Clinical Pharmacology The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Bcl-2 Targeted-Therapy for the Treatment of Head and Neck Squamous Cell Carcinoma
Recent Patents on Anti-Cancer Drug Discovery Vascular Endothelial Growth Factor (VEGF) Inhibition - A Critical Review
Anti-Cancer Agents in Medicinal Chemistry Biomarkers in Molecularly Targeted Therapy for Cancer
Recent Patents on Biomarkers Perspectives of Choroidal Neovascularization Therapy
Current Drug Targets Molecular Imaging of Therapeutic Potential of Reporter Probes
Current Drug Targets Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects
Current Cancer Drug Targets Electroporation Advances in Large Animals
Current Gene Therapy Editorial [Hot Topic: Cancer Biomarkers Guest Editor: Robert C. Rees]
Current Cancer Therapy Reviews Immunity to Tumour Antigens
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Clinical Pharmacology The Use of the Inhibitory Receptors for Modulating the Immune Responses
Current Pharmaceutical Design